Breast Program At Massachusetts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lumicell s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

Lumicell s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

United statesBarbara smithJorge ferrerIrene wapnirHoward hechlerSociety of surgical oncologyStanford university school of medicineUs food drug administrationDepartment of breast surgical oncologyLumicell incMd anderson cancer centerProfessor of surgery at harvard medical schoolBreast program at massachusettsDrug administrationNew drug applicationPremarket approval

Lumicell Introduces Further Research and Insights in Fluorescence-Guided Surgery at the Society of Surgical Oncology (SSO) Annual Meeting

NEWTON, Mass., March 25, 2024 Lumicell Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer detection during surgery, highlights presentations from clinical studies examining the use of investigational LUMISIGHT™ (pegulicianine) in combination with Lumicell™ Direct Visualization System (DVS) at the Society of Surgical Oncology Annual Meeting in Atlanta, Georgia, March 20-23, 2024.

United statesJorge ferrerBarbara smithIrene wapnirImaging drugs advisory committeeMd anderson cancer centerBreast program at massachusettsDepartment of breast surgeryDepartment of surgeryStanford university medical centerUniversity of iowa hospitalsLumicell incKey studies examinedDirect visualization systemSurgical oncology annual meetingBreast surgery

Novel Fluorescence Guidance Improves Lumpectomy Outcomes

Intracavity, real-time assessment of margins using a novel imaging agent and visualization system may improve complete resection rates, new findings show.

United statesPegulicianine lumisightBarbara smithDrug administrationHarvard medical schoolBreast program at massachusettsLumicell incNational institutes of healthAmerican society of breast surgeonsAmerican societyNovel surgical imagingTumor excisionBreast programMassachusetts general hospitalNational institutesBreast cancer

New Technology Can Identify Residual Breast Cancer During Initial Lumpectomy to Reduce Need for Second Surgery

The system is considered effective at identifying residual breast cancer following surgical resection.

United statesBarbara smithJorge ferrerHarvard medical schoolBreast program at massachusettsAmerican society of breast surgeons asbrNovel surgical imagingTumor excisionAmerican societyBreast surgeonsEarly stage breast cancerBreast programMassachusetts general hospitalFast track

Lumicell Submits New Drug Application for Lumisight Optical Imaging Agent to U S FDA for Intraoperative Breast Cancer Detection and Removal

Novel optical imaging agent highlights cancerous tissue during initial lumpectomy to enable a more complete resection as part of the investigational Lumicell Direct Visualization System

United statesBarbara smithKevin hershbergerLumicell incAmerican society of breast surgeons asbrDrug administrationBreast program at massachusettsHarvard medical schoolNew drug applicationLumisight optical imaging agentDirect visualization systemLumicell direct visualization systemNovel surgical imagingTumor excisionAmerican societyBreast surgeons